Inventor
Charles N. Serhan
Inventor
Needham, MA, US
Overview
Patents· 91 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C07KPeptides3%
C07DHeterocyclic compounds3%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
11,077,084Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors202111,077,083Oils with anti-inflammatory activity containing natural Specialized Proresolving Mediators and their precursors202111,020,406Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same202110,653,703Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same202010,568,858Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors202010,239,85014-hydroxy-docosahexaenoic acid compounds201910,233,16814-hydroxy-docosahexaenoic acid compounds201910,233,16714-hydroxy-docosahexaenoic acid compounds201910,227,291Docosahexaenoyl ethanolamides201910,154,977Anti-inflammatory particles201810,111,847Compounds and methods for modulating vascular injury20189,902,681'N-3 immunoresolvents: structures and actions'20189,611,238'14-hydroxy-docosahexaenoic acid compounds'20179,611,239'14-hydroxy-docosahexaenoic acid compounds'20179,611,240'14-hydroxy-docosahexaenoic acid compounds'20179,463,177'Compounds and methods for modulating vascular injury'20169,416,118'Docosahexaenoyl ethanolamides'20169,364,454'Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers'20168,933,270'Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma'20158,927,747'14-hydroxy-docosahexaenoic acid compounds'20158,722,654'Lipoxin analogs as novel inhibitors of angiogenesis'20148,604,229'Lipoxin analogs and methods for the treatment of periodontal disease'20138,569,542'Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma'20138,440,718'Modulation of inflammation related to columnar epithelia'20138,349,896'Aspirin-triggered lipid mediators'20138,273,792'Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it\'s natural stereoisomers'20128,119,691'Method for treating airway hyper-responsiveness with lipoxin analogs'20128,093,417'Lipoxin analogs and methods for the treatment of periodontal disease'20128,022,105'Prevention of neutrophil recruitment'20118,008,282'Lipoxin analogs as novel inhibitors of angiogenesis'20117,994,219'Approach to anti-microbial host defense with molecular shields with lipoxin compounds'20117,915,311'Approach to anti-microbial host defense with molecular shields with lipoxin compounds'20117,872,152'Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma'20117,825,271'Lipoxin compounds and their use in treating cell proliferative disorders'20107,812,054'Lipoxin analogs and methods for the treatment of periodontal disease'20107,803,557'Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors'20107,759,395'Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma'20107,741,368'Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs'20107,741,369'Lipoxin compounds and their use in treating cell proliferative disorders'20107,737,178'Aspirin-triggered lipid mediators'20107,709,669'Aspirin-triggered lipid mediators'20107,700,650'Lipoxin analogs and method for the treatment of periodontal disease'20107,615,576'Prevention of neutrophil recruitment'20097,595,341'Analogues of lipid mediators derived from ω-3 PUFAs and methods of use'20097,585,856'Resolvins: Biotemplates for novel therapeutic interventions'20097,579,494'Prevention of neutrophil recruitment'20097,378,444'Analogues of lipid mediators derived from omega-3 PUFAs and methods of use'20087,341,840'Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs'20087,294,728'Lipoxin compounds and their use in treating cell proliferative disorders'20077,288,569'Lipoxin compounds and their use in treating cell proliferative disorders'20077,227,031'Prevention of neutrophil recruitment'20077,132,451'Inhibition of TNF-α-initiated neutrophil response'20067,053,230'Aspirin-triggered lipid mediators'20067,030,159'Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs'20066,960,674'Prevention of neutrophil recruitment'20056,927,238'Regulation of phospholipase D activity'20056,887,901'Lipoxin compounds and their use in treating cell proliferative disorders'20056,864,288'Regulation of phospholipase D activity'20056,750,360'Lipoxin compounds and their use in treating cell proliferative disorders'20046,720,354'Prevention of neutrophil recruitment'20046,710,084'Inhibition of TNF-initiated neutrophil response'20046,703,423'Inhibition of TNF-initiated neutrophil response'20046,699,905'Modulation of inflammation related to columnar epithelia'20046,670,396'Aspirin-triggered lipid mediators'20036,659,282'Prevention of neutrophil recruitment'20036,653,493'Lipoxin compounds and their use in treating cell proliferative disorders'20036,635,776'Lipoxin compounds and their use in treating cell proliferative disorders'20036,627,658'Lipoxin analogs as novel inhibitors of angiogenesis'20036,620,919'Lipoxin compounds and their use in treating cell proliferative disorders'20036,569,075'Lipoxin compounds and their use in treating cell proliferative disorders'20036,458,839'Modulation of inflammation related to columnar epithelia'20026,455,755'Leukotriene B4 receptor transgenic mice'20026,433,202'Prevention of neutrophil recruitment'20026,416,965'Screening methods for presqualene disphosphate analogs'20026,387,953'Inhibition of TNF-()-initiated neutrophil response'20026,353,026'Regulation of phospholipase D activity'20026,329,425'Modulation of inflammation related to Columnar epithelia'20016,316,648'Lipoxin compounds and their use in treating cell proliferative disorders'20016,271,435'Leukotriene B4 receptor transgenic mice'20016,251,622'Screening methods for presqualene diphosphate analogs'20016,177,468'Modulation of inflammation related to columnar epithelia'20016,100,296'Modulation of inflammation related to columnar epithelia'20006,066,466'Screening methods for presqualene diphosphate analogs'20006,048,897'Lipoxin compounds and their use in treating cell proliferative disorders'20006,008,205'Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses'19995,750,354'Lipoxin transport system and uses therefor'19985,650,435'Modulation of inflammation related to columnar epithelia'19975,648,512'Lipoxin compounds'19975,441,951'Lipoxin compounds'19955,079,261'Use of lipoxin A.sub.4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis'19924,560,514'Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds'1985Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2016Patents assigned to BRIGHAM & WOMENS HOSPITAL (62)· patent assignee history
1995–2002Based in Boston, MA, US· patent location history
1999–2010Based in Wellesley, MA, US· patent location history
2003–2021Based in Needham, MA, US· patent location history
2003Based in Wellsley, MA, US· patent location history
2006–2018Patents assigned to SERHAN CHARLES N (15)· patent assignee history
2010–2016Patents assigned to UNIV SOUTHERN CALIFORNIA (6)· patent assignee history
2015Based in Neddham, MA, US· patent location history
2016–2019Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (12)· patent assignee history
2020–2021Patents assigned to SOLUTEX NA LLC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRIGHAM & WOMENS HOSPITAL | 62 | 1992–2016 |
| SERHAN CHARLES Nself | 15 | 2006–2018 |
| BRIGHAM & WOMENS HOSPITAL INC | 12 | 2016–2019 |
| UNIV SOUTHERN CALIFORNIA | 6 | 2010–2016 |
| SOLUTEX NA LLC | 5 | 2020–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Needham, Massachusetts, US | 60 | 2003–2021 |
| Wellesley, Massachusetts, US | 19 | 1999–2010 |
| Boston, Massachusetts, US | 8 | 1995–2002 |
| Neddham, Massachusetts, US | 1 | 2015 |
| Wellsley, Massachusetts, US | 1 | 2003 |